Cowen & Co. analyst Bryan Prohm weighed in with his opinions on BlackBerry Ltd (NASDAQ:BBRY) following the company’s first quarter earnings release this morning.
Cowen & Co. analyst Timothy Arcuri initiated coverage on shares of Micron Technology, Inc.
Cowen & Co. analyst Michael Gorman initiated coverage on Realty Income Corp (NYSE:O) rating the stock a Market Perform with a price target of $46.
In a research report issued today, Cowen & Co. analyst Eric Schmidt reiterated an Outperform rating on Incyte Corporation (NASDAQ:INCY), while no price target …
Cowen & Co. analyst Boris Peaker came out with some commentary on Idera Pharmaceuticals Inc (NASDAQ:IDRA), following the company’s new-found research alliance with MD Anderson to test …
Cowen’s healthcare analyst Eric Schmidt weighed in today with his thoughts on Exelixis, Inc. (NASDAQ:EXEL), after the company reported its fourth-quarter results and business update.
Celldex Therapeutics, Inc. (NASDAQ:CLDX) shares are up 17.
Cowen’s healthcare analyst Phil Nadeau came out with a research note on Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), following the company’s earnings release for the fourth-quarter.
Cowen’s healthcare analyst Boris Peaker weighed in today with a few insights on Keryx Biopharmaceuticals (NASDAQ:KERX), following yesterday’s meeting with the company’s management team. The …
Cowen analyst Boris Peaker was out today with a research note on Keryx Biopharma (NASDAQ:KERX), following Friday’s release of IMS scripts data for Aurixya. The analyst rates …
